Our Response to COVID-19: Information
|
|
Good evening,
February 5, 2021 -- A year has passed since the World Health Organization declared COVID-19 had become a global health emergency, roughly 6 weeks before calling it a global pandemic. A year ago, 29 countries had already detected the virus within their borders with about 29,000 confirmed infections and 572 identified related deaths, the world was slowly bracing itself for the onslaught of a pandemic the breath of which it had not encountered in over a century. About four thousand mobilized construction workers had just completed the record-breaking 24x7, 10-day construction of the new 269,000 square feet (25,000 square meters) one thousand-bed Huoshenshan COVID-19 quarantine hospital, near the river in Wuhan city. A month later, 88 countries were reporting coronavirus infections as the global case count passed the symbolic 100,000 mark on March 4, 2020, and the world had already buried its 3,286th victim of the new infectious disease. Scientists worldwide developed vaccine candidates within weeks of the outbreak, started phase 1 testing in March 2020 and engaged in large population testing protocols by early summer. The first approved vaccine from Pfizer-BioNTech was approved for use in the UK in the first days of December 2020, less than 9 months into the pandemic. Globally, about 106 million infections and 2.3 million covid-19 deaths have now been confirmed. Vaccination campaigns are on the way, but production and distribution challenges have resulted in disappointing results, further testing our global impatience. In the last year, we have all learned that the case counts, and the death counts are roughly equivalent on both sides of each peak. However, this time, after the last global peak was reached a month ago, we now have proven vaccines, the successful distribution of which should help further decelerate the viral spread. Let us hope distribution issues are resolved quickly, that more effective and safe vaccines become available and are massively and equitably distributed, and that the world can start a steady recovery as it also builds safeguards with maintained capacity, at the ready for the next pandemic.
COVID-19 in the world today:
- COVID-19 Global cases: 105,891,238 (+480,935)
- COVID-19 Global deaths: 2,307,415 (+14,235)
- COVID-19 Global death rate: 2.18%
-
COVID-19 Global testing*: 1,478,477,851 confirmed tests
- COVID-19 Global positivity rate: 7.2%
*: incomplete data set.
Tip: click on any of the graphs for larger and clearer images and click on READ MORE to view the complete articles. Also, please forgive the occasional typos.
|
|
Britain to test mixing and matching of COVID-19 vaccines | apnews.com
|
British scientists are starting a study Thursday to find out if it’s OK to mix and match COVID-19 vaccines.
The vaccines being rolled out now require two doses, and people are supposed to get two shots of the same kind, weeks apart.
Guidelines in Britain and the U.S. say the vaccines aren’t interchangeable but can be mixed if the same kind isn’t available for the second dose or if it’s not known what was given for the first shot.
Participants in the government-funded study will get one shot of the AstraZeneca vaccine followed by a dose from Pfizer, or vice versa.
“This study will give us greater insight into how we can use vaccines to stay on top of this nasty disease,” said Jonathan Van Tam, the U.K.’s deputy chief medical officer.
He said that given the challenges of immunizing millions of people amid a global vaccine shortage, there would be advantages to having data that could support more “flexible” immunization campaigns.
COVID-19 vaccines all train the body to recognize the coronavirus, mostly the spike protein that coats it. The ones from AstraZeneca and Pfizer use different technologies. AstraZeneca’s uses a common cold virus to carry the spike gene into the body. Pfizer’s is made by putting a piece of genetic code called mRNA — the instructions for that spike protein — inside a little ball of fat.
The British research is scheduled to run 13 months and will also test different intervals between doses, four weeks and 12 weeks apart.
A study published this week on the Russian-made Sputnik V vaccine showed it was about 91% effective in preventing COVID-19. Some immunologists credit the fact that the vaccine uses two slightly different shots, made with similar technology to AstraZeneca’s.
But the AstraZeneca and Pfizer vaccines are “so different that it’s really hard to know if that would work,” said Alexander Edwards, an associate professor in biomedical technology at Britain’s University of Reading...
|
|
|
|
Covid virus spread can be combatted through environmental testing. Why aren't we doing it? | nbcnews.com
|
By Dr. Cyrus E. Kuschner, resident of emergency medicine at North Shore University Hospital and Long Island Jewish Medical Center, Zarina Brune, M.D./P.hD. candidate at the Donald and Barbara Zucker School of Medicine at Hofstra, and Dr. Lance Becker, professor at the Feinstein Institutes for Medical Research
Until we reach the herd immunity milestone for Covid-19, when 75 percent to 90 percent of the population has been immunized through communal exposure or vaccination, we will be wearing masks, socially distancing and living in a world of glassed-off bank tellers and Lysol dependence. But one underused tool could make a significant difference in identifying and countering the virus's spread without disrupting anyone's life or surroundings: environmental testing.
Environmental sampling is an unbiased and unambiguous approach to locating where the disease is spreading. Any person who produces virus — symptomatic or asymptomatic — spreads these viral particles into the environment. Most will be inactivated because of the harsh conditions outside the human body. However, as we have seen in tracking the rapid spread of the virus around the globe, some particles remain infectious on surfaces and in the air.
By sampling and measuring the presence of virus within a given community, environmental testing can identify viral presence weeks before other measures, such as contact tracing. Among the benefits, that allows health care groups to localize outbreaks and employ targeted contact tracing in these areas...
|
|
|
The national peak of new daily cases is now four weeks old, but 29 states still reported at least 1,000 new COVID-19 infections in the last 24 hours, while related deaths are still high, essentially flat from last week (99.67%). Today the nation reported 126,125 new coronavirus infections and covid-19 has killed 3,572 Americans in the last 24 hours. The national hospitalization numbers are down but still high: 86,373 (-17% week-to-week) covid-19 patients are now hospitalized in the United States, with 17,284 (-13%) in ICU and 5,596 (-16%) people fighting for their life currently on ventilators. In the last 7 days, covid-19 has killed 23,207 Americans (-0.33%) and infected 878,287 more of our neighbors (-22.61%).
|
|
Map: Track the spread of the Covid-19 variants across the United States | nbcnews.com
|
More infectious Covid-19 variants have emerged around the world, and experts are saying the United States must adapt to a changed pandemic playing field.
According to the federal Centers for Disease Control and Prevention, these variants spread more easily, and it’s unknown whether the illness caused is more severe. The Pfizer-BioNTech vaccine was found to be only slightly less effective against the South African variant.
What hasn’t changed in the face of these variants: Experts maintain their recommendation that people wear masks.
Track the spread of the Covid-19 variants: the U.K. variant, the South African variant, and the Brazilian variant. This map will be updated.
|
|
|
|
COVID-19 in the USA
- Cases: 27,407,324 (+126,125)
- Deaths: 470,705 (+3,572)
- Death rate: 1.72%
- Testing: 320,639,539 individual tests (+1,902,644)
- Positivity rate: 8.55%
- Single-day positivity date: 6.63%
|
|
US top 5 infected states:
- California: 3,382,008 COVID-19 cases, 43,592 deaths
- Texas: 2,483,415 COVID-19 cases, 39,136 deaths
- Florida: 1,763,873 COVID-19 cases, 27,460 deaths
- New York: 1,495,835 COVID-19 cases, 44,591 deaths
- Illinois: 1,141,219 COVID-19 cases, 21,603 deaths
|
|
This week, California's 102,087 new coronavirus infections total is 32% lower than it was last week and 3,376 more Californians have died from covid-19 (12% fewer than last week). More patience, diligence, vaccinations, and compassion are needed to beat the virus.
|
|
- COVID-19 California cases: 3,382,008 (+13,102)
- COVID-19 California deaths: 43,592 (+494)
- COVID-19 California death rate: 1.29%
- COVID-19 California testing: 43,433,104 individual tests (+197,777)
- COVID-19 California positivity rate: 7.79%
- COVID-19 California single-day positivity rate: 6.62%
|
|
The Madera County Department of Public Health COVID-19 Update:
2/5/2021: Reporting 41 cases from the public, 7 from Valley State Prison, and 3 from Central California Women’s Facility (51 new total cases) bringing the total number of reported cases to 14,638.
Of the 14,638:
- 1,932 active case (including 22 Madera County residents hospitalized in Madera County)
- 12,522 recovered (76 released from isolation)
- 184 deceased
|
|
Including its prison population, Madera County is averaging 55 new cases per day (35 per 100K), with 388 new cases revealed over the last 7 days. A significant improvement over last week, but still above the average of 11 cases per day over 7 days required to switch our county from purple to red ("widespread" to "substantial") contagion risk).
Today, the seven local counties together reported 1,355 new infections and 27 new coronavirus deaths. In the combined 7 counties, COVID-19 has infected 295,703 people and has killed 3,270 residents of our region since it claimed its first central valley victim, in Madera, on March 26, 2020.
Our friends and neighbors are needlessly dying; many families are suffering. Science and the courage to follow its logic will solve this pandemic, any other discourse is inadequate.
|
|
COVID-19 in Madera + 6 local counties (+% is the positivity rate)
- Mariposa: 374 cases, 5 deaths, 14,006 tests, 2.67+%
- Merced: 27,134 cases (+116), 362 deaths (+3)
- Madera: 14,638 cases (+51), 184 deaths, 175,931 tests, 8.32+%
- Fresno: 90,126 cases (+378), 1,224 deaths, 718,467 tests, 12.54+%
- Tulare: 45,834 cases (+187), 645 deaths (+13)
-
Kings: 21,083 cases (+102), 192 deaths (+3), 271,342 tests, 7.77+%
- Kern: 96,514 cases (+521), 658 deaths, 411,973 tests, 23.43+%
COVID-19 in the 7 counties together
- 7 counties cases: 295,703 (+1,355)
- 7 counties deaths: 3,270 (+27)
- 7 counties death rate: 1.11%
|
|
The worst part of the current wave is behind us in the Central Valley. The new infections have decreased to the lowest weekly reported cases since the post-Thanksgiving, 2020 report. The total of new deaths is still very high, with only 14 below last week's report. Our sharply decreasing new case numbers are still at or above last summer's peaks and 1,150 (35.2%) of the total 3,270 covid-19 deaths in the local counties, have occurred in 2021. The Holiday season has devastated our region with 51.4% of the covid-19 deaths reported since Thanksgiving (+1,680).
|
|
Keep observing the simple yet proven safety habits of physical-distancing, mask-wearing, and frequent hand-washing, that will help drive down new infections and new deaths, to a level low enough so as to give us a chance to reopen our schools for onsite education and thus, reopen our economy. Nothing else will work until we have massively administered a safe and effective covid-19 vaccine -- currently estimated by vaccinating up to 85% of the population -- to finally reach herd immunity.
|
|
From our hearts to yours,
Fredo and Renee Martin
Workingarts Marketing, Inc.
PS: We welcome comments and questions. If you wish to review previous reports, we now host past issues here.
|
|
|
|
|
|
|